Top News
Anergis and Mymetics Start Research Collaboration Project on the use of Virosomes for Ultra-Fast Allergy Immunotherapy
SBA Member, 24.04.2018
ObsEva Announces Upcoming Presentations Related to its Endometriosis and Uterine Fibroid Development Programs with its Novel Oral GnRH Receptor Antagonist OBE2109 (KLH-2109)
SBA Member, 23.04.2018
New Novartis analyses at AAN show siponimod's efficacy on disability and cognition in secondary progressive MS patients
SBA Member, 20.04.2018
Basilea reports presentations of isavuconazole and ceftobiprole data at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
SBA Member, 20.04.2018
Novartis appoints John Tsai Head of Global Drug Development and Chief Medical Officer
SBA Member, 19.04.2018
Novartis delivered a strong first quarter and acted to become a more focused medicines company
SBA Member, 19.04.2018
Basilea shareholders approve all proposals of the Board of Directors at the Annual General Meeting of Shareholders
SBA Member, 18.04.2018
Basilea reports start of clinical phase 3 study in Japan by Asahi Kasei Pharma with antifungal isavuconazole
SBA Member, 18.04.2018
Partners
Supported by:
